Pharmaceutical products

Tender description

This framework agreement is for the supply of psychiatry generic medicines to health boards across NHS Scotland. The goods have been split into seven (7) categories, each of which is identified as a ‘Lot’. Full details of each lot is contained in Section II.2) of this notice. Supply of sodium valproate tablets, modified release tablets, capsules and granules, injection, solution, liquid and syrup to NHS Scotland in a range of presentations. The authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 suppliers will be awarded. Supply of levodopa/carbidopa/entacapone film coated tablets to NHS Scotland in a range of presentations. The authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 suppliers will be awarded. Supply of phenytoin sodium capsules, tablets and ampoules to NHS Scotland in a range of presentations. The authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 suppliers will be awarded. Supply of lamotrigine tablets and dispersible tablets to NHS Scotland in a range of presentations. The authority intends awarding a multi-supplier unranked framework agreement for the Lot and it is envisaged a maximum of 6 Suppliers will be awarded. Supply of carbamazepine tablets, suppositories, modified release tablets and liquid to NHS Scotland in a range of presentations. The authority intends awarding a multi-supplier unranked framework agreement for the Lot and it is envisaged a maximum of 6 suppliers will be awarded. Supply of all other psychiatry generic medicines to NHS Scotland in a range of presentations. The authority intends awarding each line within this lot to a single supplier. Supply of midazolam oromucosal solution to NHS Scotland in a range of presentations. The authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 suppliers will be awarded.